A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors.
- Published in:
- 2011
- By:
- Publication type:
- Report
Works by Wang, Liuchun
Results: 12
1
2
Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements.
- Published in:
- Medical Science Monitor, 2019, v. 25, p. 675, doi. 10.12659/MSM.913054
- By:
- Publication type:
- Article
3
Incidence and clinical implication of tumor cavitation in patients with advanced non-small cell lung cancer induced by Endostar, an angiogenesis inhibitor.
- Published in:
- Thoracic Cancer, 2014, v. 5, n. 5, p. 438, doi. 10.1111/1759-7714.12115
- By:
- Publication type:
- Article
4
Osimertinib plus anlotinib for advanced NSCLC with acquired EGFR T790M mutation: results from a multicenter phase II study with ctDNA analysis.
- Published in:
- BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04044-8
- By:
- Publication type:
- Article
5
Circulating endothelial cells and tumor blood volume as predictors in lung cancer.
- Published in:
- Cancer Science, 2013, v. 104, n. 4, p. 445, doi. 10.1111/cas.12097
- By:
- Publication type:
- Article
6
Nuclear to Cytoplasmic Transport Is a Druggable Dependency in HDAC7‐driven Small Cell Lung Cancer (Adv. Sci. 14/2025).
- Published in:
- Advanced Science, 2025, v. 12, n. 14, p. 1, doi. 10.1002/advs.202570096
- By:
- Publication type:
- Article
7
Nuclear to Cytoplasmic Transport Is a Druggable Dependency in HDAC7‐driven Small Cell Lung Cancer.
- Published in:
- Advanced Science, 2025, v. 12, n. 14, p. 1, doi. 10.1002/advs.202413445
- By:
- Publication type:
- Article
8
CD31‐labeled circulating endothelial cells as predictor in anlotinib‐treated non‐small‐cell lung cancer: Analysis on ALTER‐0303 study.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 7, p. 3011, doi. 10.1002/cam4.1584
- By:
- Publication type:
- Article
9
Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma.
- Published in:
- Molecular Diagnosis & Therapy, 2011, v. 15, n. 6, p. 347, doi. 10.1007/BF03256470
- By:
- Publication type:
- Article
10
Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01823-w
- By:
- Publication type:
- Article
11
Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023.
- Published in:
- Portal Hypertension & Cirrhosis, 2024, v. 3, n. 3, p. 139, doi. 10.1002/poh2.89
- By:
- Publication type:
- Article
12
Prognostic Significance of Combined Biomarkers in Small Cell Lung Cancer.
- Published in:
- Clinical Laboratory, 2020, v. 66, n. 9, p. 1677, doi. 10.7754/Clin.Lab.2020.191002
- By:
- Publication type:
- Article